Direct comparative effectiveness and safety between non-vitamin K antagonist oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation: a systematic …

G Li, GYH Lip, A Holbrook, Y Chang, TB Larsen… - European journal of …, 2019 - Springer
The non-vitamin K antagonist oral anticoagulants (NOACs) have been increasingly
prescribed in clinical practice for stroke prevention in patients with nonvalvular atrial …

Direct comparative effectiveness and safety between non-vitamin K antagonist oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation: a systematic …

G Li, GYH Lip, A Holbrook, Y Chang, TB Larsen, X Sun… - 2018 - wlv.openrepository.com
The non-vitamin K antagonist oral anticoagulants (NOACs) have been increasingly
prescribed in clinical practice for stroke prevention in patients with nonvalvular atrial …

Direct comparative effectiveness and safety between non-vitamin K antagonist oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation: a systematic …

G Li, GYH Lip, A Holbrook, Y Chang… - European Journal of …, 2019 - vbn.aau.dk
The non-vitamin K antagonist oral anticoagulants (NOACs) have been increasingly
prescribed in clinical practice for stroke prevention in patients with nonvalvular atrial …

Direct comparative effectiveness and safety between non-vitamin K antagonist oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation: a systematic …

G Li, GYH Lip, A Holbrook, Y Chang… - European journal …, 2019 - pubmed.ncbi.nlm.nih.gov
The non-vitamin K antagonist oral anticoagulants (NOACs) have been increasingly
prescribed in clinical practice for stroke prevention in patients with nonvalvular atrial …

Direct comparative effectiveness and safety between non-vitamin K antagonist oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation

G Li, GYH Lip, A Holbrook, Y Chang, TB Larsen… - European Journal of …, 2019 - JSTOR
The non-vitamin K antagonist oral anticoagulants (NOACs) have been increasingly
prescribed in clinical practice for stroke prevention in patients with nonvalvular atrial …

[引用][C] Direct comparative effectiveness and safety between non-vitamin K antagonist oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation: a …

G Li, GYH Lip, A Holbrook, Y Chang… - European Journal of …, 2018 - cir.nii.ac.jp
Direct comparative effectiveness and safety between non-vitamin K antagonist oral
anticoagulants for stroke prevention in nonvalvular atrial fibrillation: a systematic review and …

Direct comparative effectiveness and safety between non-vitamin K antagonist oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation: a systematic …

G Li, GYH Lip, A Holbrook, Y Chang… - European Journal of …, 2019 - inis.iaea.org
[en] The non-vitamin K antagonist oral anticoagulants (NOACs) have been increasingly
prescribed in clinical practice for stroke prevention in patients with nonvalvular atrial …

[PDF][PDF] Direct comparative effectiveness and safety between non-vitamin K antagonist oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation: a …

G Li, GYH Lip, A Holbrook, Y Chang, TB Larsen, X Sun… - researchgate.net
The non-vitamin K antagonist oral anticoagulants (NOACs) have been increasingly
prescribed in clinical practice for stroke prevention in patients with nonvalvular atrial …

Direct comparative effectiveness and safety between non-vitamin K antagonist oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation: a systematic …

G Li, GYH Lip, A Holbrook, Y Chang… - European Journal …, 2019 - search.proquest.com
The non-vitamin K antagonist oral anticoagulants (NOACs) have been increasingly
prescribed in clinical practice for stroke prevention in patients with nonvalvular atrial …

Direct comparative effectiveness and safety between non-vitamin K antagonist oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation: a systematic …

G Li, GYH Lip, A Holbrook, Y Chang… - European Journal …, 2019 - search.ebscohost.com
The non-vitamin K antagonist oral anticoagulants (NOACs) have been increasingly
prescribed in clinical practice for stroke prevention in patients with nonvalvular atrial …